Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections.

Charlton CL, Babady E, Ginocchio CC, Hatchette TF, Jerris RC, Li Y, Loeffelholz M, McCarter YS, Miller MB, Novak-Weekley S, Schuetz AN, Tang YW, Widen R, Drews SJ.

Clin Microbiol Rev. 2018 Dec 12;32(1). pii: e00042-18. doi: 10.1128/CMR.00042-18. Print 2019 Jan.

PMID:
30541871
2.

Rapid detection of four non-fermenting Gram-negative bacteria directly from cystic fibrosis patient's respiratory samples on the BD MAX™ system.

Rocchetti TT, Silbert S, Gostnell A, Kubasek C, Jerris R, Vong J, Widen R.

Pract Lab Med. 2018 May 24;12:e00102. doi: 10.1016/j.plabm.2018.e00102. eCollection 2018 Nov.

3.

Clinical Evaluation of the iCubate iC-GPC Assay for Detection of Gram-Positive Bacteria and Resistance Markers from Positive Blood Cultures.

Granato PA, Unz MM, Widen RH, Silbert S, Young S, Heflin KL, Conover MS, Buchan BW, Ledeboer NA.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00485-18. doi: 10.1128/JCM.00485-18. Print 2018 Sep.

4.

Multicenter Evaluation of the Xpert MRSA NxG Assay for Detection of Methicillin-Resistant Staphylococcus aureus in Nasal Swabs.

Yarbrough ML, Warren DK, Allen K, Burkholder D, Daum R, Donskey C, Knaack D, LaMarca A, May L, Miller LG, Parenti DM, Peterson L, Tan TY, Widen R, Hernandez DR, Wolk DM, Burnham CA.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01381-17. doi: 10.1128/JCM.01381-17. Print 2018 Jan.

5.

Evaluation of the BD Max StaphSR Assay for Detecting Methicillin-Resistant Staphylococcus aureus (MRSA) and Methicillin-Susceptible S. aureus (MSSA) in ESwab-Collected Wound Samples.

Silbert S, Gostnell A, Kubasek C, Widen R.

J Clin Microbiol. 2017 Sep;55(9):2865-2867. doi: 10.1128/JCM.00641-17. Epub 2017 Jun 14. No abstract available.

6.

Evaluation of the New FecalSwab System for Maintaining Stability of Stool Samples Submitted for Molecular Tests.

Silbert S, Gostnell A, Kubasek C, Widen R.

J Clin Microbiol. 2017 May;55(5):1588-1590. doi: 10.1128/JCM.00273-17. Epub 2017 Mar 15. No abstract available.

7.

Detection of Mycobacterium chelonae, Mycobacterium abscessus Group, and Mycobacterium fortuitum Complex by a Multiplex Real-Time PCR Directly from Clinical Samples Using the BD MAX System.

Rocchetti TT, Silbert S, Gostnell A, Kubasek C, Campos Pignatari AC, Widen R.

J Mol Diagn. 2017 Mar;19(2):295-302. doi: 10.1016/j.jmoldx.2016.10.004.

PMID:
28190461
8.

Detection of Group B Streptococcus Directly from Collected ESwab Samples by Use of the BD Max GBS Assay.

Silbert S, Rocchetti TT, Gostnell A, Kubasek C, Widen R.

J Clin Microbiol. 2016 Jun;54(6):1660-1663. doi: 10.1128/JCM.00445-16. Epub 2016 Apr 6.

9.
10.

Evaluation of BD Max StaphSR and BD Max MRSAXT Assays Using ESwab-Collected Specimens.

Silbert S, Kubasek C, Galambo F, Vendrone E, Widen R.

J Clin Microbiol. 2015 Aug;53(8):2525-9. doi: 10.1128/JCM.00970-15. Epub 2015 May 27.

11.

Laboratory evaluation of the BD MAX MRSA assay.

Widen R, Healer V, Silbert S.

J Clin Microbiol. 2014 Jul;52(7):2686-8. doi: 10.1128/JCM.00237-14. Epub 2014 May 14.

12.

Comparison of ESwab with traditional swabs for detection of methicillin-resistant Staphylococcus aureus using two different walk-away commercial real-time PCR methods.

Silbert S, Kubasek C, Uy D, Widen R.

J Clin Microbiol. 2014 Jul;52(7):2641-3. doi: 10.1128/JCM.00315-14. Epub 2014 Apr 23.

13.

Differentiation of Klebsiella pneumoniae carbapenemase (KPC) variants by pyrosequencing.

Monteiro J, Widen RH, Pignatari AC, Kubasek C, Silbert S.

J Microbiol Methods. 2014 May;100:42-5. doi: 10.1016/j.mimet.2014.02.013. Epub 2014 Mar 11.

PMID:
24631557
14.

Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patients.

Reich RR, Lengacher CA, Kip KE, Shivers SC, Schell MJ, Shelton MM, Widen RH, Newton C, Barta MK, Paterson CL, Farias JR, Cox CE, Klein TW.

Biol Res Nurs. 2014 Oct;16(4):429-37. doi: 10.1177/1099800413519494. Epub 2014 Jan 28.

15.

Rapid diagnosis of Mycobacterium abscessus endophthalmitis.

Rolfe NE, Garcia C, Widen RH, Taylor SP.

J Med Microbiol. 2013 Jul;62(Pt 7):1089-91. doi: 10.1099/jmm.0.051771-0. Epub 2013 Apr 11.

PMID:
23579395
16.

Stemness of B-cell progenitors in multiple myeloma bone marrow.

Boucher K, Parquet N, Widen R, Shain K, Baz R, Alsina M, Koomen J, Anasetti C, Dalton W, Perez LE.

Clin Cancer Res. 2012 Nov 15;18(22):6155-68. doi: 10.1158/1078-0432.CCR-12-0531. Epub 2012 Sep 17.

17.

Rapid detection of carbapenemase genes by multiplex real-time PCR.

Monteiro J, Widen RH, Pignatari AC, Kubasek C, Silbert S.

J Antimicrob Chemother. 2012 Apr;67(4):906-9. doi: 10.1093/jac/dkr563. Epub 2012 Jan 9.

PMID:
22232516
18.

Lymphocyte recovery after breast cancer treatment and mindfulness-based stress reduction (MBSR) therapy.

Lengacher CA, Kip KE, Post-White J, Fitzgerald S, Newton C, Barta M, Jacobsen PB, Shelton MM, Moscoso M, Johnson-Mallard V, Harris E, Loftus L, Cox C, Le N, Goodman M, Djeu J, Widen RH, Bercu BB, Klein TW.

Biol Res Nurs. 2013 Jan;15(1):37-47. doi: 10.1177/1099800411419245. Epub 2011 Nov 14.

PMID:
22084404
19.

Identification of transcription start sites and preferential expression of select CB2 transcripts in mouse and human B lymphocytes.

Sherwood TA, Nong L, Agudelo M, Newton C, Widen R, Klein TW.

J Neuroimmune Pharmacol. 2009 Dec;4(4):476-88. doi: 10.1007/s11481-009-9169-z. Epub 2009 Sep 16.

20.

Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.

Keeling WB, Myers AR, Stone PA, Heller L, Widen R, Back MR, Johnson BL, Bandyk DF, Shames ML.

J Surg Res. 2009 Dec;157(2):223-6. doi: 10.1016/j.jss.2008.06.050. Epub 2008 Aug 14.

PMID:
19560786
21.

Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer.

Lengacher CA, Johnson-Mallard V, Post-White J, Moscoso MS, Jacobsen PB, Klein TW, Widen RH, Fitzgerald SG, Shelton MM, Barta M, Goodman M, Cox CE, Kip KE.

Psychooncology. 2009 Dec;18(12):1261-72. doi: 10.1002/pon.1529.

PMID:
19235193
22.

Comparison of DNA pyrosequencing with alternative methods for identification of mycobacteria.

Heller LC, Jones M, Widen RH.

J Clin Microbiol. 2008 Jun;46(6):2092-4. doi: 10.1128/JCM.02001-07. Epub 2008 Apr 16.

23.

Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes.

Agudelo M, Newton C, Widen R, Sherwood T, Nong L, Friedman H, Klein TW.

J Neuroimmune Pharmacol. 2008 Mar;3(1):35-42. doi: 10.1007/s11481-007-9088-9. Epub 2007 Sep 27.

24.

Immune system changes during simulated planetary exploration on Devon Island, high arctic.

Crucian B, Lee P, Stowe R, Jones J, Effenhauser R, Widen R, Sams C.

BMC Immunol. 2007 May 23;8:7.

25.

Legionella pneumophila infection up-regulates dendritic cell Toll-like receptor 2 (TLR2)/TLR4 expression and key maturation markers.

Rogers J, Hakki A, Perkins I, Newton C, Widen R, Burdash N, Klein T, Friedman H.

Infect Immun. 2007 Jun;75(6):3205-8. Epub 2007 Mar 19.

26.

Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome.

Epling-Burnette PK, Painter JS, Rollison DE, Ku E, Vendron D, Widen R, Boulware D, Zou JX, Bai F, List AF.

Leukemia. 2007 Apr;21(4):659-67. Epub 2007 Feb 15.

PMID:
17301813
27.

Staphylococcal cassette chromosome mec and Panton-Valentine leukocidin characterization of methicillin-resistant Staphylococcus aureus clones.

Moroney SM, Heller LC, Arbuckle J, Talavera M, Widen RH.

J Clin Microbiol. 2007 Mar;45(3):1019-21. Epub 2006 Dec 27.

28.
29.

Evaluation of two TaqMan PCR assays for the detection of HIV-1 proviral DNA in blood samples.

Moroney SM, Heller LC, Widen RH.

J Microbiol Methods. 2006 May;65(2):350-3. Epub 2005 Sep 16.

PMID:
16169104
30.

The novel differentiation of human blood mononuclear cells into CD1a-negative dendritic cells is stimulated in the absence of exogenous cytokines by an extract prepared from pinecones.

Bradley WG, Widen RH, Weiser AM, Powers JJ, Fountain LB, Punjwani P, Lofgren SM, Hadzic T, Klein R, Green WH, Tanaka A.

Int Immunopharmacol. 2003 Feb;3(2):209-23.

PMID:
12586602
32.

Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages.

Yamaguchi H, Haranaga S, Widen R, Friedman H, Yamamoto Y.

Infect Immun. 2002 May;70(5):2392-8.

33.
34.

Modulation of CB1 mRNA upon activation of murine splenocytes.

Noe SN, Newton C, Widen R, Friedman H, Klein TW.

Adv Exp Med Biol. 2001;493:215-21.

PMID:
11727768
35.

Intracellular induction of the Bartonella henselae virB operon by human endothelial cells.

Schmiederer M, Arcenas R, Widen R, Valkov N, Anderson B.

Infect Immun. 2001 Oct;69(10):6495-502.

36.

Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation.

Lee SF, Newton C, Widen R, Friedman H, Klein TW.

Eur J Pharmacol. 2001 Jul 6;423(2-3):235-41.

PMID:
11448490
37.

Differential induction of gamma interferon in Legionella pneumophila-infected macrophages from BALB/c and A/J mice.

Salins S, Newton C, Widen R, Klein TW, Friedman H.

Infect Immun. 2001 Jun;69(6):3605-10.

38.

Anti-CD40, anti-CD3, and IL-2 stimulation induce contrasting changes in CB1 mRNA expression in mouse splenocytes.

Noe SN, Newton C, Widen R, Friedman H, Klein TW.

J Neuroimmunol. 2000 Oct 2;110(1-2):161-7.

PMID:
11024546
39.

Transcriptional activation of the htrA (High-temperature requirement A) gene from Bartonella henselae.

Resto-Ruiz SI, Sweger D, Widen RH, Valkov N, Anderson BE.

Infect Immun. 2000 Oct;68(10):5970-8.

40.
41.

Detection of intracellular/intranuclear antigens in tumor cells.

Widen RH, Becker JL.

Methods Mol Biol. 1998;91:57-65. No abstract available.

PMID:
9664481
42.

Detection of intracellular/intranuclear antigens. Applications in leukemia/lymphoma analysis.

Widen RH.

Methods Mol Biol. 1998;91:47-55. No abstract available.

PMID:
9664480
43.

The use of flow cytometry to detect intracellular cytokine production in individual cells.

Crucian BE, Widen RH.

Methods Mol Biol. 1998;91:37-46. No abstract available.

PMID:
9664479
44.

Infectious issues in human fetal neural transplantation.

Holt DA, Nauert GM, Othberg AI, Randall TS, Willing AE, Widen RH, Hauser RA, Sanberg PR, Olanow CW, Freeman TB.

Cell Transplant. 1997 Nov-Dec;6(6):553-6. No abstract available.

PMID:
9440864
45.

Assessment of intracellular TAP-1 and TAP-2 in conjunction with surface MHC class I in plasma cells from patients with multiple myeloma.

Crucian BE, Moscinski LC, Androlewicz M, Ballester OF, Widen RH, Yu H.

Br J Haematol. 1997 Aug;98(2):426-32.

PMID:
9266943
46.

Differential immunologic modulatory effects of tetrahydrocannabinol as a function of age.

Ramarathinam L, Pross S, Plescia O, Newton C, Widen R, Friedman H.

Mech Ageing Dev. 1997 Jun;96(1-3):117-26.

PMID:
9223115
47.

Cytogenetic, morphologic and oncogene analysis of a cell line derived from a heterologous mixed mullerian tumor of the ovary.

Becker JL, Papenhausen PR, Widen RH.

In Vitro Cell Dev Biol Anim. 1997 May;33(5):325-31.

PMID:
9196889
49.

Alterations in peripheral blood mononuclear cell cytokine production in response to phytohemagglutinin in multiple sclerosis patients.

Crucian B, Dunne P, Friedman H, Ragsdale R, Pross S, Widen R.

Clin Diagn Lab Immunol. 1995 Nov;2(6):766-9.

50.

Human peritoneal macrophage and T lymphocyte populations in mild and severe endometriosis.

Becker JL, Widen RH, Mahan CS, Yeko TR, Parsons AK, Spellacy WN.

Am J Reprod Immunol. 1995 Sep;34(3):179-87.

PMID:
8561876

Supplemental Content

Support Center